MT HB60

Extends the prohibition against pharmacy benefit managers or health carriers requiring federally certified health entities to identify 340B drugs from June 1, 2025 to June 1, 2029

Changes the statute of limitations for securities violation civil actions from 2 years after the violation occurs to 1 year after discovery of the violation

Allows domestic insurers with minimum capital and surplus of $15 million to be designated as domestic surplus lines insurers, enabling them to write surplus lines insurance while being considered unauthorized insurers only for that specific purpose

Removes the $50 fee requirement for nonprofit organizations (religious, educational, charitable, etc.) to claim securities exemptions from the Commissioner

Updates telehealth insurance coverage requirements to clarify that deductibles, coinsurance, and copayments for telehealth services may not exceed those applicable to in-person medical services